DUBLIN, CA, USA, November 15, 2022 /EINPresswire.com/ -- Opkey, the industry leader in test automation for packaged applications, is proud to announce the release of ...

Assessment of patient reported outcomes (PROs) completion patterns in patients with cancer: Examining real-world data. Using real-world evidence (RWE) in regulatory decision making: A study of 6 ...

Managing system risk is paramount for organizations to protect their data and ensure operational continuity. Security Impact Analysis (SIA) is a critical component of this process, offering a ...

Among 6,475 publications identified, 31 evaluated PFS and OS among subgroups of patients who received NGS-informed cancer management. PFS and OS were significantly longer among patients who were ...

Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab. Objectives: ...